Merck Business Analysis

In: Business and Management

Submitted By talittle1275
Words 1954
Pages 8
Merck: Business Analysis
Tamikiia Brown
MGT521
July 11, 2011
Sharon Palmitier

Merck: Business Analysis
Merck is a flourishing research-driven pharmaceutical company, which discovers, develops, manufacturers, and promotes an extensive variety of human and animal health products. Although Merck is one of the biggest pharmaceutical companies of the world, they still come across problems today while striving to sustain a lead against its competition. Merck has achieved success with its lengthy history of breakthrough drugs and the development of three significant pharmaceutical products: antibiotics, vitamins, and hormones. Merck’s success relies heavily on its management and how they modify the business model in place to that of the ever-changing economy.
Influence of Economic Trends
The global pharmaceutical market is likely to undergo a wide variety of changes with new competition arising in India, China, Malaysia, South Korea, and Indonesia. This new competition has a growing economy and has made a difference between the product cost and disposable income of consumers. According to NASDAQ (2011),“ Global pharmaceutical market sales are expected to grow at a 4-7% through the year 2013 largely being driven by the growing access to health care in emerging economic regions” (para. 2-5). Short-term growth within this area is stimulated by the United States market, as it continues to be the largest pharmaceutical market in the world. A focal point on research and development in special drugs and generic drugs will remain a strong means to meet 2011 goals of earning $315 billion dollar in sales within the United States.
Strategies
Merck & Co., Inc. has outlined its long-term strategic goals in how the company devises to develop and market medicines and vaccines worldwide. Merck plans to enhance the value of its medicines and vaccines through…...

Similar Documents

Business Analysis

...Week 2 Analysis Report BUSN460 Senior Project Professor: Raouf Ghattas January 20, 2013 Issue 1: CanGo is in need of a formal business plan. A formal business plan includes a mission and vision statement to help define the business and where the company would like to go in the future. As the owner/operator of CanGo, Elizabeth never developed a formal business plan for the business from the beginning and therefore had no documented blueprint for the business to speak of. Perfect starting issue! Recommendation: A business plan is a written document that demonstrates persuasively that enough products or services can be sold at a profit for your firm to become a viable business. The three primary reasons for writing business plans are (1) to aid you in determining the feasibility of your business idea, (2) to attract capital for starting up, and (3) to provide direction for your business after it is in operation. CanGo needs a written that will help find omissions and flaws in their ideas by allowing other people to critically review and analyze the plan. A business plan tells you what your business objectives are; when, where, why, and how your business will accomplish its objectives; and who will be involved in running the business. This planning process will help define CanGo’s short term goals and help determine the actions that need to be taken to accomplish them and then gather and commit the necessary resources (Hatten, 2008). The mission statement......

Words: 1795 - Pages: 8

Merck

...Analysis on Merck's Acquisition of Medco The reason behind a lot of Mergers & Acquisitions is due to the many changing forces in the business environment. Competitiveness, survival and profitability are key factors to the M&A. In the case of Merck, the plan for acquisition of Medco followed as competitors such as SmithKline Beecham, Roche Holdings Limited Eli Lilly and Company announced their plans to acquire other pharmaceutical companies and Health systems such as those of Diversified Pharmaceutical Services Incorporate, Syntel Corporation and PSC Health Systems, respectively. There still exist concerns on the executive team's side regarding whether or not to move forward with the acquisitions. Some favor the move and some do not. There are concerns about the synergies and integration of a highly research oriented pharmaceutical company such as Merck with a drug marketing company like Medco. In addition, there are concerns on the need to continue increasing the stock price for Merck and about the different business cultures between the two and how they may not mix well. This could result in an expensive failure. On the other hand, the marketing department fully supports the acquisition. The acquisition will provide leverage for marketing opportunities in the managed care area, given the size of the database for Medco. So, the plan is for Merck to acquire Medco for a $6.6 billion offer. Clear and substantive analysis of the M&A is needed for better decision making.......

Words: 527 - Pages: 3

Merck Case Analysis

...Stakeholder Analysis – Merck Identify Key Stakeholders In the pharmaceutical industry, there is much to consider and constantly change in order to continue profits. In order to continue profits, a main factor, as said by former Merck president George W Merck, is the people. Merck said, “We try to never forget that medicine is for the people”. The first group of stakeholders has to be the people, or the consumer. The consumer is actually using the product from Merck and Co. and ultimately determines the success of the business. The second group of stakeholders is the employees. Employees determine the performance of the company. The employees consist of the executives and the lower management. A third group is the research and developers. A new drug must be created in order for the company to succeed. Ray Gilmartin, CEO, invests millions to create new drugs for Merck. One important example is the race to create one’s own Cox-2-inhibiting painkiller. A fourth group of key stakeholders is the doctors. Sales representatives try to sell Merck’s product to doctor’s offices. $102 million was spent just on sales representatives. Successful sales representatives lead to doctors writing prescriptions to patients for Merck’s products. Lastly, investors are a key stakeholder. An investor in the business cares about the downfalls and upcoming of a company because it is their money. The investor wants to receive a return on their initial investment and for the company to do......

Words: 600 - Pages: 3

Business Analysis, Swot Analysis

...SUMMARY Over 6 years of Business Analysis experience with in-depth knowledge of business processes in health care, banking and financial industries ▪ Experienced in interacting with business users to identify their needs, gathering requirements and authoring Business Requirement Documents (BRD), Functional Requirement Document (FRD) and Software Requirement Specification (SRS) across the deliverables of a project. ▪ In-Depth Knowledge in facilitating Joint Application Development (JAD), Rapid Application Development (RAD) and Joint Requirement Planning (JRP) sessions, interviews, workshops and requirement elicitation sessions with end-users, clients, stakeholders and development team. ▪ Strong Knowledge with Iterative approach for Software Development as per Rational Unified Process (RUP). Involved in inception, elaboration, construction & transition phases using rational tools like Requisite Pro, Clear Case and Clear Quest during various phases of RUP. ▪ Experienced in Business Analysis, SWOT Analysis, Gap Analysis, Risk Analysis, Disaster Recovery Planning, Testing and Project Planning. ▪ Extensive knowledge of Medicaid, Medicare, Procedural and Diagnostic codes and Claims Process. ▪ Expertise in EDI and HIPAA Testing Privacy with multiple transactions exposure such as Inbound Claims 837-Institutional, 837-Professional, 837-Dental, 835-Claim Payment/Remittance Advise, 270/271-Eligibility Benefit Inquiry/Response, 276/277-Claim Status......

Words: 2730 - Pages: 11

Merck

...UNIVERSITY OF WASHINGTON Graduate School of Business Administration Finance 553 CAPITAL INVESTMENT PLANNING Winter 2003 Professor Robert C. (Rocky) Higgins 306 Mackenzie Hall Tel: 543-4379 E-mail: rhiggins@u.washington.edu Homepage: http://us.badm.washington.edu/higgins/ (From here you’re one click from the class page) Office Hours: M, W: 10:30 – 12:00 COURSE OBJECTIVE Capital Investment Planning is a case course examining corporate investment decisions and related issues in financial strategy. The course is intended as a continuation of Finance 552, Corporate Planning and Financing, and is suitable for generalists and finance specialists who seek a solid grounding in corporate financial management. Finance 555 may be substituted for Finance 552 as a prerequisite. Principal topics include: use of discounted cash flow analysis to evaluate investment opportunities, estimating capital costs, or discount rates, capital budgeting systems and their affect on resource allocation decisions, valuing a company or division, merger analysis, corporate restructuring including leveraged buyouts, and issues in financial strategy. When you complete this course, you should be able to: Estimate an investment’s relevant costs and benefits Estimate a company's weighted-average cost of capital and understand its role in investment decision making Use discounted cash flow techniques, decision trees, and simulation to analyze investment opportunities Value (i...

Words: 3270 - Pages: 14

Merck Acquisition of Medco Study and Analysis

...Merck Acquisition of Medco Study and Analysis Abstract Corporate mergers and acquisitions (M&A) have become popular across the globe during the last two decades due to globalization, liberalization, technological developments, and competitive business environment (Fisher & Siburg, 2009). The synergistic gains from M&A may result from efficient management, economies of scale, profitable use of assets, exploitation of market power, and the use of complementary resources (Mitchell et al, 2004). Theoretically it is assumed that mergers improve the performance of the acquiring firm due to increased market share and synergy impact. This paper reviews the acquisition of Medco Medco Containment Services, Inc. (Medco) by Merck & Company (Merck) and cites reasons for acquisition of Medco. Merck's acquisition of Medco represents a $6.6 billion bet on where the future of the pharmaceutical industry lies (Nichols, 1994). In today's managed-care environment, Vagelos (CEO of Merck in 1993) argues, the company that best controls the information flow from doctor to patient to pharmacist to plan sponsor has the greatest chance of succeeding. Medco has information on 38 million patients, which allows Merck to learn a lot more about how its drugs are prescribed and used and, ultimately, how effective they are in fighting disease. Owning Medco can also help Merck increase its market share in an industry in which no company......

Words: 2407 - Pages: 10

Merck - an Analysis

...FIN-516 – WEEK 2 – MINI – CASE Merck & Co., Inc. by M. Luisa Ribeiro 1. Merck & Co., Inc. is a company in the Pharmaceutical Sector. The headquarters are in Whitehouse Station, NJ but it has global presence providing prescription pharmaceuticals, animal health, and consumer care, which include animal health, consumer care products and pharmaceutical medicines which include vaccines, biologic therapies. Merck’s products are marketed directly and through joint ventures. 2. Merck’s operating risks: Merck’s operating risks include recently expired and expiring patented medications which are and soon will be facing market competition from generics, and fewer that optimal products in the development stage to be brought to market. Additionally, some European countries, in an effort to reduce and curtail costs as they are coping with the effects of austerity measures, are imposing a mandatory switch to generic drugs. Some disappointing results of new products in the development stage are posing a risk to the company that needs to stay in compliance, particularly in the face of law suits for past and current medications under Merck’s patent. With changing environment in the health care field in the US, Merck’s efforts to expand operations and distribution to developing countries, also posed a challenge to the company, as developing regions, such as Africa and developing countries such as India, China, Russia and Brazil, that may not offer a stable political,......

Words: 1473 - Pages: 6

Business Analysis

...I. Economic Analysis 5 II. Balance Scorecard 8 III. Project Management 10 Activity Definition 10 Scope Definition 10 Work Breakdown Structure and Schedule 11 Conclusion 12 References 13 Executive Summary The most important managerial decision facing my corporation is how to remain competitive in the real estate market. In order to remain competitive, we must increase profits by evaluating most aspects of our business. Azteca Partners, Inc. was created to facilitate the purchasing, repairing, and selling of distressed properties. During the last year, most projects have been over-budget and over-schedule. This project will addresses or reduce critical aspects of the real estate business. First, Azteca Partners must decide whether to expand into the neighboring county. It is a decision we have discussed but not analyzed. The project will be used to analysis data from the current county and the proposed county. After all data is obtained, we will be able to make a sound business decision. Secondly, the issue of over-run projects will be analyzed using MS Project 2007. Each task will be schedule and an estimated date of less than 60 days will be the goal of each repair project. The tasks will be scheduled in a systematic approach that will reduce delays or slack time. Lastly, Azteca Partners will implement new strategies aimed at improving the overall business health of......

Words: 1173 - Pages: 5

Merck

...9-201-023 REV: MARCH 25, 2003 RICHARD S. RUBACK Merck & Company: Evaluating a Drug Licensing Opportunity Rich Kender, Vice President of Financial Evaluation & Analysis at Merck, was working with his team to decide whether his company should license Davanrik, a new drug with the potential to treat both depression and obesity. The small pharmaceutical concern that developed the drug, LAB Pharmaceuticals, lacked the resources to complete the lengthy approval process, manufacture the compound, and market the drug. LAB had approached Merck with an offer to license the compound. Under this agreement, Merck would be responsible for the approval of Davanrik, its manufacture, and its marketing. The company would pay LAB an initial fee, a royalty on all sales, and make additional payments as Davanrik completed each stage of the approval process. Merck In 2000, Merck & Co., Inc. was a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a broad range of human and animal health products, directly and through its joint ventures, and provides pharmaceutical benefit management services (PBM) through Merck-Medco Managed Care. Since 1995, Merck had launched 15 new products including Vioxx™ for the treatment of osteoarthritis, Fosamax™ for the treatment of osteoporosis and Singulair™ for treating asthma. The Company earned $5.9 billion on 1999 sales1 of $32.7 billion, about a 20% increase from 1998. Exhibits 1 and 2 contain Merck’s Income...

Words: 2360 - Pages: 10

Business Analysis

...and Analysis of Critical Issues and its Impact on the Business Performance and Strategic Direction Bellevue University Assignment 9.1 May 4, 2015 Business situation analysis and its impact on performance and strategic direction Business situational analysis is defined as internal and external factors that affect the business’s environment in different way (the situational analysis, 2011). There are five situational factors that most businesses focus on: legal, regulatory, social, technological and ethical. Thus, each factor drives the business decision making. Therefore, situational analysis allows the business to determine the business strengths, weaknesses, opportunities and threats (The situation analysis, 2011) and make beneficial decisions. However, legal and ethical factors are areas where issues comes at any level of the business. In this topic, it’s important to describe and analyze the critical issues around legal and ethical factors and how they impact the business performance and strategic direction. A legal factor relates to new laws or directives governing how businesses behave. This can be in relation to other businesses, customers or the environment. Indeed, businesses need to watch out for new laws put on the market. In fact, businesses’ activities are restrained by laws and regulations (A hands-on introduction to business fundamentals in foundation, 2014). Those laws could be local, national or international and all depend on where the business is......

Words: 650 - Pages: 3

Merck

...Merck & Medco: A Comparative Analysis By: Larry Lloyd Keller Graduate School of Management FIN 561 Mergers & Acquisitions (Online) Professor Gene Smith September 19, 2015 Table of Contents Table of Contents…………………………………………………………………………………………………………………...i Executive Summary…………………………………………………..……………………………………………………………1 Overview of Pharmaceutical Industry…………………….…………………………………………………………......2 S.W.O.T Analysis..……………………..................................................................................................3-5 Impact on Marketing and Sales…………………………………………….………………………………………………..5-6 Marketing and Sales Considerations……………………………………………………………………………….........6-7 Operational Considerations………………………………………..…………………………………………….……………7-8 Financial Considerations………………………………………………………………………………………………………...8-9 Recommendations………………………………………………………………………………………………………………..9-11 References……………………………………………………………….…………………………………………………………….12 i. Executive Summary Merck & Co. is one of the world’s leading pharmaceutical companies, is seeking to acquire Medco Containment Services, a leading managed prescription drug benefit company, for $6 billion dollars. After the merger, Merck & Co. will seek to strengthen their position in healthcare industry, by not only selling prescription drugs used by millions of consumers, but also having a larger say in how the medicines are used by......

Words: 2468 - Pages: 10

Merck Case - Business Ethic

...Vagelos as CEO and for Merck as a company in deciding whether to invest in Dr. Campbell’s idea? The stakes for Roy Vagelos as CEO would be the high level of risk to succeed, the strong change to have a low level of profitability even after the success, and the advantage of Dr Campbell’s project, less investment needed and government aid in tax. And the stakes for Merck as a company would be the corporate ethic it has pursued and Merck’s need to develop another new successful prescription. Q2. How does Merck pick from among the many ways to “do good” and many drugs to invest in? Merck took 12 years and $200 million to bring a new drug to market on the average. And thousands of scientists worked on new ideas and following new leads. It uses various methods to choose the project through extensive review and analysis on the basis of the likelihood of success, the existing market, competition, potential safety problems, manufacturing feasibility and patent. Q3. How much of its research budget should Merck invest in drugs that will likely produce a substandard return on its investment? The research budget should be considered in research/development expenses, expected income with the tax benefit from the government, and mostly the effect and impact based on the corporate ethics and morale. Q4. What should Merck tell a shareholder who might complain about a decision to invest in research on river blindness? The overall corporate philosophy of Merck is based on......

Words: 336 - Pages: 2

Business Analysis

...Introduction SWOT analysis as a part of business analysis plays significant role to get knowledge about a particular organization. By conducting SWOT analysis, an organization may improve its effectiveness through strengthening its current status, grabbing opportunities and reducing weaknesses and protecting business from threats (Hitt, Ireland & Hoskisson, 2008). In addition to this, SWOT analysis is quite appropriate to make decision to invest in a particular company by an investor. Being a mutual fund manager, this paper will discuss about SWOT analysis of Walt Disney for getting clarity about investmentdecision. In context of SWOT analysis, key strengths, weaknesses, opportunities and threats of Walt Disney would be presented to get clarity about the company's current position. It would be quite effective to mutual fund manager to make investment decision for Walt Disney. SWOT Analysis Walt Disney is one of the diversified well-knownbrands of Entertainment Company. Itdeals in different segments of entertainment industry in terms ofanimated films, theme parks, resorts and studios etc. (The Walt Disney Company, 2012).In context of Walt- Disney, several strengths, weaknesses, opportunities and threats are associated with the company that are presented as below: Strengths: Walt Disney is a well-known brand of entertainment industry that has unique positioning around the world. It is the key strength of the company as global customers know the company for innovation......

Words: 2186 - Pages: 9

Merck

...Merck – Business Analysis MGMT 521 October 17, 2011 Dr. Patrick E. Murray Merck – Business Analysis A mutual fund manager invests in many securities. Experiences and success open new opportunities to future investments. Merck is one of the largest and well-known pharmaceutical companies in the world. The decision to invest is determent on many factors. This includes a SWOT analysis of Merck and taking information from this analysis to decide whether to invest. Internal and external stakeholders along with their wants and needs are identified. Finally, an explanation of Merck's handling current and future stakeholder needs is determined. This research helps in making the decision to invest or not with Merck. SWOT Analysis |Strengths |Weaknesses | | | | |A diversified product portfolio |Reduction in OTC (over-the-counter) products | | | | |Global efforts to decrease maternity mortality |Possible reduction in workforce | |ration | | | | ......

Words: 1532 - Pages: 7

Business Analysis

...PHILIP KOTLER MARKETING MANAGEMENT SUMMARY PREPARED BY SUBHANK RAJGURU PGDM, BIMTECH INDEX Chapter 1 Marketing in the 21st century ................................................... 3 Chapter 2 Building Customer Satisfaction Value and Retention.............. 19 Chapter 3 Winning Markets : Market Oriented Strategic Planning......... 25 Chapter4 Gathering Information and measuring market demand ........... 31 Chapter 5 Scanning the Marketing Environment...................................... 42 CHAPTER –6 Analyzing Consumer markets & Buying Behavior ........... 55 CHAPTER 7 ANALYZING BUSINESS MARKETS AND BUSINESS BUYING BEHAVIOR ................................................................................. 63 Chapter 8 Dealing With the Competition ................................................... 69 CHAPTER 9 Identifying Market Segments and Selecting Target Markets ....................................................................................................................... 76 Chapter 10 Positioning the Market Offering Through the Product Life Cycle ............................................................................................................. 86 Chapter 11 Developing New Products ...................................................... 106 CHAPTER 13 Product & Product Mixes ................................................. 118 Chapter 14 : Designing and Managing Services...................................... 126 Chapter......

Words: 70844 - Pages: 284